Lincomed (Lincomycin)

Lincomycin, the active ingredient in Lincomed, is a lincosamide presented as an injectable solution for intramuscular and intravenous use. It treats infections caused by susceptible Gram‑positive bacteria, including skin, soft‑tissue, bone, joint and respiratory tract infections, in adult and pediatric patients where indicated.

GNH USA supplies Lincomed as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution. Clients benefit from consistent product availability and regulatory support across multiple markets.

Lincomycin is employed to treat bacterial infections that are susceptible to lincosamide antibiotics. - Skin and soft tissue infections: eradicates the causative Gram‑positive organisms and promotes healing of the affected area. - Bone and joint infections: eliminates infection within bone and articulations, supporting recovery of function. - Respiratory tract infections: clears bacterial pathogens in the lungs and airways, improving respiratory symptoms. - Severe infections caused by susceptible Gram‑positive bacteria: provides broad coverage for serious systemic infections when alternative agents are unsuitable.

Lincomycin may be associated with several adverse reactions, ranging from mild to serious. Common Side Effects: - Nausea: mild gastrointestinal upset. - Diarrhea: loose stools that may be self‑limiting. - Injection site pain: discomfort or erythema at the administration site. Serious or Rare Side Effects: - Clostridioides difficile‑associated diarrhea: severe colitis requiring medical attention. - Anaphylaxis: acute, potentially life‑threatening allergic reaction. - Hepatic dysfunction: elevated liver enzymes or jaundice.

When using Lincomycin, clinicians should observe several precautionary measures to minimize risks. - Assess renal function: adjust dosing in patients with impaired kidney function. - Monitor hepatic function: watch for signs of liver toxicity during therapy. - Use with caution in patients with a history of colitis: risk of C. difficile infection may increase. - Avoid in individuals with known hypersensitivity to lincomycin or other lincosamides: discontinue if allergic reaction occurs. - Adjust dose in severe renal impairment: consider reduced frequency or alternative agents. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Lincomycin can interact with other medicines, affecting efficacy or safety. Major Interactions (Avoid): - Erythromycin: competitive inhibition of metabolism may increase lincomycin levels. - Clindamycin: cross‑resistance can reduce therapeutic effect. - Neuromuscular blocking agents: potentiation may cause prolonged paralysis. - Live vaccines: immunosuppression may diminish vaccine efficacy. Moderate Interactions (Monitor Closely): - Warfarin: lincomycin may enhance anticoagulant effect, requiring INR monitoring. - Phenytoin: possible reduction in phenytoin concentrations. - Oral contraceptives: may experience decreased hormonal efficacy.